Desensitization and resensitization of beta-adrenergic receptors in a smooth muscle cell line. 1985

P J Scarpace, and L A Baresi, and D A Sanford, and I B Abrass

Exposure to the beta-adrenergic agonist, metaproterenol, elicits extensive receptor loss and desensitization of adenylate cyclase activity in the hamster DDT1, MF-2 cell line. The reappearance of beta-adrenergic receptors and restoration of adenylate cyclase activity were investigated. Receptor reappearance was investigated under conditions in which lost receptors were not detectable either on the cell surface or within the cell. Exposure to metaproterenol resulted in a 3-5-fold decrease in beta-adrenergic receptor affinity for agonist, an 85% reduction in beta-adrenergic receptor number per cell, and a 65% reduction in isoproterenol-stimulated adenylate cyclase activity without any change in NaF-stimulated enzyme activity. The rate of reappearance of the lost receptors was proportional to the concentration of metaproterenol to which the cells were initially exposed. Metaproterenol, at a concentration of 250 microM, induced long-term receptor loss which required 16 days in fresh media devoid of metaproterenol before the full complement of receptors reappeared. This prolonged receptor loss may be due to residual metaproterenol; however, the resensitization of isoproterenol-stimulated adenylate cyclase activity was restored 2 days after removal of metaproterenol. The lag period for the reappearance of receptors was shortened by incubation with either the beta-adrenergic antagonist, nadalol, or the glucocorticoid, methylprednisolone. Both pharmaceuticals reversed receptor down-regulation and up-regulated receptor number in control cells, although the extent and time course of restoration were different. These data suggest that the process of resensitization in DDT1 cells involves rapid restoration of adenylate cyclase activity and a slower reappearance of receptors over a time period of six population doublings.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D007890 Leiomyosarcoma A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1865) Leiomyosarcoma, Epithelioid,Leiomyosarcoma, Myxoid,Epithelioid Leiomyosarcoma,Epithelioid Leiomyosarcomas,Leiomyosarcomas,Leiomyosarcomas, Epithelioid,Leiomyosarcomas, Myxoid,Myxoid Leiomyosarcoma,Myxoid Leiomyosarcomas
D008647 Mesocricetus A genus in the order Rodentia and family Cricetidae. One species, Mesocricetus auratus or golden hamster is widely used in biomedical research. Hamsters, Golden,Hamsters, Golden Syrian,Hamsters, Syrian,Mesocricetus auratus,Syrian Golden Hamster,Syrian Hamster,Golden Hamster,Golden Hamster, Syrian,Golden Hamsters,Golden Syrian Hamsters,Hamster, Golden,Hamster, Syrian,Hamster, Syrian Golden,Syrian Hamsters
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D009248 Nadolol A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for MIGRAINE DISORDERS and for tremor. Corgard,SQ-11725,Solgol,SQ 11725,SQ11725
D009921 Metaproterenol A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM. Orciprenaline,Alotec,Alupent,Astmopent,Metaprel,Metaproterenol Polistirex,Metaproterenol Sulfate,Orciprenaline Sulfate,Polistirex, Metaproterenol
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D011943 Receptors, Adrenergic, beta One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS. Adrenergic beta-Receptor,Adrenergic beta-Receptors,Receptors, beta-Adrenergic,beta Adrenergic Receptor,beta-Adrenergic Receptor,beta-Adrenergic Receptors,Receptor, Adrenergic, beta,Adrenergic Receptor, beta,Adrenergic beta Receptor,Adrenergic beta Receptors,Receptor, beta Adrenergic,Receptor, beta-Adrenergic,Receptors, beta Adrenergic,beta Adrenergic Receptors,beta-Receptor, Adrenergic,beta-Receptors, Adrenergic

Related Publications

P J Scarpace, and L A Baresi, and D A Sanford, and I B Abrass
January 1998, Advances in pharmacology (San Diego, Calif.),
P J Scarpace, and L A Baresi, and D A Sanford, and I B Abrass
December 1985, Pharmacological research communications,
P J Scarpace, and L A Baresi, and D A Sanford, and I B Abrass
September 1997, The American journal of physiology,
P J Scarpace, and L A Baresi, and D A Sanford, and I B Abrass
May 1976, Proceedings of the National Academy of Sciences of the United States of America,
P J Scarpace, and L A Baresi, and D A Sanford, and I B Abrass
October 1996, Pediatric pulmonology,
P J Scarpace, and L A Baresi, and D A Sanford, and I B Abrass
February 1985, Molecular pharmacology,
P J Scarpace, and L A Baresi, and D A Sanford, and I B Abrass
November 1984, Biochemical and biophysical research communications,
P J Scarpace, and L A Baresi, and D A Sanford, and I B Abrass
January 1988, Life sciences,
P J Scarpace, and L A Baresi, and D A Sanford, and I B Abrass
January 2006, The American surgeon,
P J Scarpace, and L A Baresi, and D A Sanford, and I B Abrass
September 2001, American journal of respiratory cell and molecular biology,
Copied contents to your clipboard!